Related Experiment Videos
Accelerated cell-mediated broncho-obstructive reaction to inhaled stepronin: a case report
A Romano1, M Di Fonso, F Mormile
1Istituto di Medicina Interna e Geriatria, Università Cattolica del S. Cuore, Rome, Italy.
Allergy
|April 1, 1996
Summary
A young man experienced a severe allergic reaction, including breathing difficulties and facial rash, after using the mucolytic drug stepronin. Testing confirmed a delayed hypersensitivity reaction, highlighting potential risks of this medication.
Area of Science:
- Pulmonology
- Allergy and Immunology
- Dermatology
Background:
- Mucolytic agents are commonly used to treat respiratory conditions.
- Adverse drug reactions can manifest through various mechanisms, including hypersensitivity.
- Stepronin is a mucolytic drug used for respiratory ailments.
Observation:
- A 20-year-old male presented with obstructive bronchial reaction and maculopapular facial rash 8 hours post-aerosolized stepronin treatment.
- Clinical presentation suggested a hypersensitivity reaction to the mucolytic drug.
Findings:
- Intradermal and patch testing with stepronin indicated a positive reaction.
- Bronchial challenge tests confirmed airway hyperreactivity.
- Histological examination of skin patch tests supported a cell-mediated hypersensitivity mechanism.
Implications:
- This case highlights a potential delayed hypersensitivity reaction to stepronin.
- Cell-mediated hypersensitivity should be considered in patients developing respiratory and dermatological symptoms after stepronin use.
- Further investigation into the immunologic profile of stepronin reactions may be warranted.